drugset / Trial / NCT00733226

Effect of OM-85 BV on Wheezing Related Morbidity in Children With Recurrent Wheezing

NCT00733226

Phase 4 Completed 80 enrolled Kecioren Education and Training Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The purpose of this study is to determine whether OM-85 BV (Broncho-Vaxom)has any effect on respiratory infections, infection related wheezing attacks, beta-2 agonist use, duration of attacks and effect on serum cytokine levels.

Timeline

Start
2007-08
Primary completion
2008-09
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Broncho-Vaxom Other / unclassified 3.5 mg Oral

Indications